Logo image of SYM

SYMBOTIC INC (SYM) Stock Fundamental Analysis

USA - NASDAQ:SYM - US87151X1019 - Common Stock

60.73 USD
+3.68 (+6.45%)
Last: 9/22/2025, 9:08:28 PM
58.1 USD
-2.63 (-4.33%)
Pre-Market: 9/23/2025, 5:22:43 AM
Fundamental Rating

4

SYM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 129 industry peers in the Machinery industry. The financial health of SYM is average, but there are quite some concerns on its profitability. SYM is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SYM was profitable.
In the past year SYM had a positive cash flow from operations.
In the past 5 years SYM always reported negative net income.
In multiple years SYM reported negative operating cash flow during the last 5 years.
SYM Yearly Net Income VS EBIT VS OCF VS FCFSYM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

SYM has a Return On Assets of -0.87%. This is in the lower half of the industry: SYM underperforms 69.77% of its industry peers.
SYM has a worse Return On Equity (-7.50%) than 74.42% of its industry peers.
Industry RankSector Rank
ROA -0.87%
ROE -7.5%
ROIC N/A
ROA(3y)-1.41%
ROA(5y)-24.27%
ROE(3y)-9735.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SYM Yearly ROA, ROE, ROICSYM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

1.3 Margins

Looking at the Gross Margin, with a value of 16.86%, SYM is doing worse than 79.07% of the companies in the same industry.
In the last couple of years the Gross Margin of SYM has grown nicely.
The Profit Margin and Operating Margin are not available for SYM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.86%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.29%
GM growth 5YN/A
SYM Yearly Profit, Operating, Gross MarginsSYM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

More info and screens

6

2. Health

2.1 Basic Checks

SYM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SYM has more shares outstanding
There is no outstanding debt for SYM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SYM Yearly Shares OutstandingSYM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SYM Yearly Total Debt VS Total AssetsSYM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

SYM has an Altman-Z score of 13.35. This indicates that SYM is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SYM (13.35) is better than 95.35% of its industry peers.
There is no outstanding debt for SYM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 13.35
ROIC/WACCN/A
WACC9.89%
SYM Yearly LT Debt VS Equity VS FCFSYM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

SYM has a Current Ratio of 1.08. This is a normal value and indicates that SYM is financially healthy and should not expect problems in meeting its short term obligations.
SYM has a worse Current ratio (1.08) than 85.27% of its industry peers.
A Quick Ratio of 0.98 indicates that SYM may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.98, SYM is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.08
Quick Ratio 0.98
SYM Yearly Current Assets VS Current LiabilitesSYM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 186.39% over the past year.
The Revenue has grown by 27.17% in the past year. This is a very strong growth!
Measured over the past years, SYM shows a very strong growth in Revenue. The Revenue has been growing by 77.99% on average per year.
EPS 1Y (TTM)186.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%678.95%
Revenue 1Y (TTM)27.17%
Revenue growth 3Y92.19%
Revenue growth 5Y77.99%
Sales Q2Q%20.38%

3.2 Future

Based on estimates for the next years, SYM will show a very strong growth in Earnings Per Share. The EPS will grow by 121.68% on average per year.
The Revenue is expected to grow by 23.18% on average over the next years. This is a very strong growth
EPS Next Y741.4%
EPS Next 2Y343.48%
EPS Next 3Y169.77%
EPS Next 5Y121.68%
Revenue Next Year27.07%
Revenue Next 2Y23.63%
Revenue Next 3Y25.73%
Revenue Next 5Y23.18%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SYM Yearly Revenue VS EstimatesSYM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
SYM Yearly EPS VS EstimatesSYM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.5 1 1.5 2 2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 404.87, the valuation of SYM can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of SYM indicates a slightly more expensive valuation: SYM is more expensive than 72.87% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SYM to the average of the S&P500 Index (27.41), we can say SYM is valued expensively.
SYM is valuated quite expensively with a Price/Forward Earnings ratio of 88.14.
SYM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SYM is more expensive than 68.99% of the companies in the same industry.
SYM is valuated expensively when we compare the Price/Forward Earnings ratio to 22.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 404.87
Fwd PE 88.14
SYM Price Earnings VS Forward Price EarningsSYM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400

4.2 Price Multiples

69.77% of the companies in the same industry are cheaper than SYM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 206.85
EV/EBITDA N/A
SYM Per share dataSYM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

SYM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SYM's earnings are expected to grow with 169.76% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y343.48%
EPS Next 3Y169.77%

More info and screens

0

5. Dividend

5.1 Amount

SYM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SYMBOTIC INC

NASDAQ:SYM (9/22/2025, 9:08:28 PM)

Premarket: 58.1 -2.63 (-4.33%)

60.73

+3.68 (+6.45%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-17 2025-11-17/bmo
Inst Owners82.54%
Inst Owner Change0.08%
Ins Owners0.46%
Ins Owner Change-0.41%
Market Cap35.86B
Analysts70
Price Target48.71 (-19.79%)
Short Float %14.49%
Short Ratio6.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)26.19%
Min EPS beat(2)-121.96%
Max EPS beat(2)174.34%
EPS beat(4)2
Avg EPS beat(4)-15.32%
Min EPS beat(4)-121.96%
Max EPS beat(4)174.34%
EPS beat(8)4
Avg EPS beat(8)-18.85%
EPS beat(12)4
Avg EPS beat(12)-49.64%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.32%
Min Revenue beat(2)2.7%
Max Revenue beat(2)9.94%
Revenue beat(4)3
Avg Revenue beat(4)8.06%
Min Revenue beat(4)-1.85%
Max Revenue beat(4)21.43%
Revenue beat(8)6
Avg Revenue beat(8)8.02%
Revenue beat(12)10
Avg Revenue beat(12)13.62%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)17.22%
PT rev (3m)47.67%
EPS NQ rev (1m)45.93%
EPS NQ rev (3m)42.2%
EPS NY rev (1m)0%
EPS NY rev (3m)27.01%
Revenue NQ rev (1m)-1.26%
Revenue NQ rev (3m)-5.1%
Revenue NY rev (1m)0.04%
Revenue NY rev (3m)1.26%
Valuation
Industry RankSector Rank
PE 404.87
Fwd PE 88.14
P/S 16.82
P/FCF 206.85
P/OCF 151.39
P/B 170.15
P/tB 532.86
EV/EBITDA N/A
EPS(TTM)0.15
EY0.25%
EPS(NY)0.69
Fwd EY1.13%
FCF(TTM)0.29
FCFY0.48%
OCF(TTM)0.4
OCFY0.66%
SpS3.61
BVpS0.36
TBVpS0.11
PEG (NY)0.55
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.87%
ROE -7.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.86%
FCFM 8.13%
ROA(3y)-1.41%
ROA(5y)-24.27%
ROE(3y)-9735.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.29%
GM growth 5YN/A
F-Score6
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 156.6%
Cap/Sales 2.98%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.08
Quick Ratio 0.98
Altman-Z 13.35
F-Score6
WACC9.89%
ROIC/WACCN/A
Cap/Depr(3y)206.19%
Cap/Depr(5y)195.83%
Cap/Sales(3y)2.24%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)186.39%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%678.95%
EPS Next Y741.4%
EPS Next 2Y343.48%
EPS Next 3Y169.77%
EPS Next 5Y121.68%
Revenue 1Y (TTM)27.17%
Revenue growth 3Y92.19%
Revenue growth 5Y77.99%
Sales Q2Q%20.38%
Revenue Next Year27.07%
Revenue Next 2Y23.63%
Revenue Next 3Y25.73%
Revenue Next 5Y23.18%
EBIT growth 1Y34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year253.85%
EBIT Next 3Y95.26%
EBIT Next 5Y70.45%
FCF growth 1Y61.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.72%
OCF growth 3YN/A
OCF growth 5YN/A